Molecular mechanisms of muscular dystrophies: old and new players. by Davies, K, Nowak, K

Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. by Nowak, K, Davies, K

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours. by Sewry, C, Nowak, K, Ehmsen, J, Davies, K

Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy by Sewry, C, Nowak, K, Ehmsen, J, Davies, K

Muscular dystrophies related to the cytoskeleton/nuclear envelope. by Nowak, K, McCullagh, K, Poon, E, Davies, K

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies by Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M

Get full text

Reconstruction of the Casting Technology in the Bronze Age on the Basis of Investigations and Visualisation of Casting Moulds by Garbacz-Klempka A., Kwak Z., Żak P. L., Szucki M., Ścibior D., Stolarczyk T., Nowak K.

Get full text

Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms. by Ilkovski, B, Nowak, K, Domazetovska, A, Maxwell, A, Clement, S, Davies, K, Laing, N, North, K, Cooper, S

Mutant actins that cause congenital myopathy affect sarcomeric protein expression in patient muscle and produce intranuclear and cytoplasmic aggregates in cultured myoblasts by Ilkovski, B, Nowak, K, Domazetovska, A, Maxwell, A, Clement, S, Davies, K, Laing, N, North, K, Cooper, S

Cardiac α-actin over-expression therapy in dominant ACTA1 disease. by Ravenscroft, G, McNamara, E, Griffiths, L, Papadimitriou, J, Hardeman, E, Bakker, A, Davies, K, Laing, N, Nowak, K

Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. by Ravenscroft, G, Jackaman, C, Bringans, S, Papadimitriou, J, Griffiths, L, McNamara, E, Bakker, A, Davies, K, Laing, N, Nowak, K

Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies by Ravenscroft, G, Jackaman, C, Bringans, S, Papadimitriou, J, Griffiths, L, McNamara, E, Bakker, A, Davies, K, Laing, N, Nowak, K

Trophy hunting: Bans create opening for change. by Nowak, K, Lee, PC, Marino, J, Mkono, M, Mumby, H, Dobson, A, Harvey, R, Lindsay, K, Lusseau, D, Sillero-Zubiri, C, Et al.

Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression by Ravenscroft, G, Jackaman, C, Sewry, C, McNamara, E, Squire, SE, Potter, A, Papadimitriou, J, Griffiths, L, Bakker, A, Davies, K, Laing, N, Nowak, K

Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression. by Ravenscroft, G, Jackaman, C, Sewry, C, McNamara, E, Squire, SE, Potter, A, Papadimitriou, J, Griffiths, L, Bakker, A, Davies, K, Laing, N, Nowak, K

Investigation of a transgenic mouse model of familial dilated cardiomyopathy. by Song, W, Dyer, E, Stuckey, D, Leung, M, Memo, M, Mansfield, C, Ferenczi, M, Liu, K, Redwood, C, Nowak, K, Harding, S, Clarke, K, Wells, D, Marston, S

Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse. by Song, W, Dyer, E, Stuckey, D, Copeland, O, Leung, M, Bayliss, C, Messer, A, Wilkinson, R, Tremoleda, J, Schneider, MD, Harding, SE, Redwood, C, Clarke, K, Nowak, K, Monserrat, L, Wells, D, Marston, S

A mutant skeletal muscle alpha-actin gene, fused to enhanced green fluorescent protein (EGFP) produces a unique myopathic mouse model by Nowak, K, Ravenscroft, G, Jackaman, C, Lim, E, Sewry, C, Potter, A, Squire, S, Fisher, R, Baker, E, Feng, J, Marston, S, Fabian, V, Morling, P, Bakker, A, Griffiths, L, Papadimitriou, J, Davies, K, Laing, N

Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. by Nowak, K, Ravenscroft, G, Jackaman, C, Filipovska, A, Davies, S, Lim, E, Squire, SE, Potter, A, Baker, E, Clément, S, Sewry, C, Fabian, V, Crawford, K, Lessard, J, Griffiths, L, Papadimitriou, J, Shen, Y, Morahan, G, Bakker, A, Davies, K, Laing, N

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope by Mercer, L, Abhishek, A, Kavirayani, A, Ahmed, A, Davidson, A, Foulkes, A, Jones, C, Nash, C, Rose-Parfitt, E, Dhillon, E, Zabate, G, Twohig, H, De Vere, H, Scott, J, Reynolds, J, Holmes, J, Hartley, K, Warrier, K, Nowak, K, Parsons, K, Bechman, K, Bray, L, Adikari, M, Wood, N